Video della Dr Stephanie Kaye-Barrett
Osteoporosis is a condition that causes our bones to become thinner and more susceptible to fractures as we age. In today's online interview, we invite highly esteemed consultant rheumatologist Dr Stephanie Kaye-Barrett to discuss the symptoms and causes of the condition, as well giving expert insight on the best treatment options for patients. If you are concerned about symptoms of osteoporosis or wish to discuss a treatment plan, you can book a consultation with Dr Kaye-Barrett by visiting her Top Doctors profile: https://www.topdoctors.co.uk/doctor/stephanie-barrett ✔ Follow us on Instagram: https://bit.ly/3fSrqXb ✔ Follow us on Facebook: https://bit.ly/3t5kGsW ✔ Follow us on Twitter: https://bit.ly/39TidKh
There is uncertainty exactly what kind of condition fibromyalgia is; whether it's neurological or an autoimmune condition. Extreme fatigue and chronic pain - among other symptoms - are, however, undeniably a burden on patient's quality of life and require expert treatment. Dr Stephanie Kaye-Barrett is a leading physician and rheumatologist that treats fibromyalgia. She addresses issues that affect patients and provides a detailed response as to how it's being treated at the moment, among many more useful points. If you would like to book an appointment with Dr Kaye-Barrett, you can do so here: https://www.topdoctors.co.uk/doctor/stephanie-barrett ✔ Follow us on Instagram: https://bit.ly/3fSrqXb ✔ Follow us on Facebook: https://bit.ly/3t5kGsW ✔ Follow us on Twitter: https://bit.ly/39TidKh
Recorded on 27 August 2020, as part of The Royal Society of Medicine's events programme. Organised by the Rheumatology & Rehabilitation Section. This lecture examines paediatric hyper-inflammatory syndrome seen in children with the SARS-CoV2 (COVID-19) infection. This rare but potentially fatal condition in children affected with COVID-19 requires prompt recognition and treatment. Topics covered include the differences between hyper-inflammatory syndrome of non-infectious aetiology and how to recognise and promptly treat the syndrome in the context of COVID-19. See all upcoming RSM events: https://rsm.ac/3kHR00T Find out more about Rheumatology & Rehabilitation Section at the RSM: https://rsm.ac/3iA2CkU Learn more about becoming an RSM member: https://rsm.ac/3kHPrQE
Recorded on 20 May 2020, as part of The Royal Society of Medicine's events programme. Organised by the Rheumatology & Rehabilitation Section. Rheumatologists have been surprised by the presentations and potential parallels with autoimmune diseases and systemic sclerosis (SSc). Professor Denton, a global expert in systematic sclerosis, has been working on the frontline in COVID-19 care at the Royal Free Hospital in London, and Dr Stephanie Kaye-Barrett, Consultant Physician and Rheumatologist, here talk about the parallel aspects of autoimmune diseases, systemic sclerosis and COVID-19. Interviewed by, Dr Stephanie Kaye-Barrett MD, FRCP, Consultant Physician and Rheumatologist, and Medical Director at the Chelsea Rheumatology Clinic See all upcoming RSM events: https://rsm.ac/3kHR00T Find out more about Rheumatology & Rehabilitation Section at the RSM: https://rsm.ac/3iA2CkU Learn more about becoming an RSM member: https://rsm.ac/3kHPrQE
Recorded on 4 May 2020, as part of The Royal Society of Medicine's events programme. Organised by the Rheumatology & Rehabilitation Section. Dr Jessica Manson, Consultant Rheumatologist at UCLH and Dr Stephanie Kaye-Barrett, Consultant Physician and Rheumatologist, discuss cytokine storms and how they are a common complication, not only of COVID-19 and flu, but also other respiratory diseases caused by coronaviruses such as SARS and MERS. Interviewed by, Dr Stephanie Kaye-Barrett MD, FRCP, Consultant Physician and Rheumatologist, and Medical Director at the Chelsea Rheumatology Clinic See all upcoming RSM events: https://rsm.ac/3kHR00T Find out more about Rheumatology & Rehabilitation Section at the RSM: https://rsm.ac/3iA2CkU Learn more about becoming an RSM member: https://rsm.ac/3kHPrQE
Recorded on 29 April 2020, as part of The Royal Society of Medicine's events programme. Organised by the Rheumatology & Rehabilitation Section. Recently a number of drugs, which have been used in rheumatology for decades, have been found to be beneficial in the various stages of COVID-19, according to case reports and limited studies. This webinar looks at the evidence behind these reports and studies, and the new trials which will involve the use of these drugs. Interviewed by, Dr Stephanie Kaye-Barrett MD, FRCP, Consultant Physician and Rheumatologist, and Medical Director at the Chelsea Rheumatology Clinic See all upcoming RSM events: https://rsm.ac/3kHR00T Find out more about Rheumatology & Rehabilitation Section at the RSM: https://rsm.ac/3iA2CkU Learn more about becoming an RSM member: https://rsm.ac/3kHPrQE
Recorded on Thursday 22 October 2020, as part of the Royal Society of Medicine's COVID-19 Series. In this episode, we discussed how to analyse data from blood tests to guide immune treatments such as corticosteroids, and how cytokine pathway blockers are being used to calm the deadly cytokine storm and its consequences. The RSM COVID-19 Series is for health professionals, by health professionals; a series of talks dedicated to give healthcare workers on the frontline, regular and easy-to-access updates from healthcare leaders on COVID-19. Learn more about all our webinars here: https://rsm.ac/2UDvcsg Join in the conversation online using #RSMLive Consider making a donation to the RSM: www.rsm.ac/donation All views expressed in this webinar are of the speakers themselves and not of the RSM.